Benign Prostatic Hyperplasia (BPH) is a common condition that affects many men as they age, causing the prostate to enlarge ...

Frequent urination or a weak urine system might be due to an underlying serious condition like Benign Prostatic Hyperplasia.

This page compiles essential information on generic and brand-name drugs specifically used for Benign Prostatic Hyperplasia treatment.Here, you can explore dosages, prices, side effects ...

Benign Prostatic Hyperplasia is a non-cancerous enlargement of the prostate gland Read this article to know how this ...

Prostate Treatment Market. The global benign prostatic hyperplasia (BPH) prostate treatment market is set for consistent ...

Third-generation α 1-adrenergic antagonists are pharmacologically uroselective in that they are competitive antagonists for prostatic α 1A-receptors. [16,17] Blockade of these receptors relaxes ...

The volume of distribution of alfuzosin is 2.5 L/kg, and 90% of each dose is protein bound. Because the volume of distribution of alfuzosin is lower in some elderly patients, the initial dose in ...

Recognizing TULSA is being used by urologists to treat an unrivalled variety of prostate cancer and/or BPH patients, Profound is developing a novel set of software modules under the TULSA-AI ® brand ...

Prostatic artery embolization or PAE is a minimally invasive treatment that helps improve lower urinary tract symptoms caused ...

Britain's King Charles has been recently diagnosed with cancer while undergoing treatment for an enlarged prostate or benign prostatic hyperplasia. While the type and stage of malignancy still remains ...

Pharmacy Plus has set a new standard in prostate health care with the launch of Duostam, an innovative treatment for Benign Prostatic Hyperplasia (BPH), ...